9-134036286-T-C
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_007371.4(BRD3):c.1682A>G(p.Tyr561Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000683 in 1,611,498 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_007371.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BRD3 | NM_007371.4 | c.1682A>G | p.Tyr561Cys | missense_variant | Exon 10 of 12 | ENST00000303407.12 | NP_031397.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRD3 | ENST00000303407.12 | c.1682A>G | p.Tyr561Cys | missense_variant | Exon 10 of 12 | 1 | NM_007371.4 | ENSP00000305918.6 | ||
BRD3 | ENST00000371834 | c.*278A>G | 3_prime_UTR_variant | Exon 10 of 10 | 1 | ENSP00000360900.2 | ||||
BRD3 | ENST00000473349.1 | n.74A>G | non_coding_transcript_exon_variant | Exon 2 of 4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152186Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000321 AC: 8AN: 249564Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 134944
GnomAD4 exome AF: 0.0000733 AC: 107AN: 1459312Hom.: 0 Cov.: 31 AF XY: 0.0000524 AC XY: 38AN XY: 725716
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152186Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1682A>G (p.Y561C) alteration is located in exon 10 (coding exon 9) of the BRD3 gene. This alteration results from a A to G substitution at nucleotide position 1682, causing the tyrosine (Y) at amino acid position 561 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at